Agreement - May 30, 2016
Lipidor, Cadila announce agreement
Lipidor AB and Cadila Pharmaceuticals Limited, one of the largest pharmaceutical manufacturing groups in India, have entered into a collaboration agreement on the commercialization of a sprayable anti-psoriatic product consisting of the generic Vitamin D analogue, Calcipotriol, formulated with Lipidor´s patented lipid-based drug delivery technology, AKVANO. The product targets patients with mild to moderate psoriasis. […]
Acquisition - October 2, 2014
Cadila Pharmaceuticals buys BioChromix NewCo
Cadila Pharmaceuticals Sweden AB has announced the acquisition of Swedish BioChromix NewCo. BioChromix NewCo was founded in 2013, based the technology previously developed by BioChromix AB and BioChromix Pharma AB, to explore a class of conjugated heteocyclic compounds for the treatment of protein misfolding. Cadila Pharmaceuticals will continue to develop the preclinical and clinical development […]
Collaboration - January 14, 2014
Cadila Pharmaceuticals ties up with NovaSAID for drug development
Cadila Pharmaceuticals on Monday announced a partnership with Swedish NovaSAID to develop innovative treatment for inflammation and pain management. The duo will develop new treatment for inflammation and pain in conditions such as rheumatoid arthritis. NovaSAID is a company in Karolinska Development’s portfolio. The companies will collaborate around pre-clinical and clinical development of drug candidates […]
